BTAI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
BTAI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
BioXcel Therapeutics's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $-72.36 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.
Total Stockholders Equity is used to calculate Book Value per Share. BioXcel Therapeutics's Book Value per Share for the quarter that ended in Mar. 2024 was $-2.15. The ratio of a company's debt over equity can be used to measure how leveraged this company is. BioXcel Therapeutics's Debt-to-Equity for the quarter that ended in Mar. 2024 was -1.41.
The historical data trend for BioXcel Therapeutics's Total Stockholders Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioXcel Therapeutics Annual Data | |||||||||||||||||
Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Total Stockholders Equity | Get a 7-Day Free Trial | 26.90 | 206.70 | 221.67 | 76.78 | -56.51 |
BioXcel Therapeutics Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Total Stockholders Equity | Get a 7-Day Free Trial | 53.01 | 5.86 | -40.61 | -56.51 | -72.36 |
BioXcel Therapeutics (NAS:BTAI) Total Stockholders Equity Explanation
1. Total Stockholders Equity is used to calculate Book Value per Share.
BioXcel Therapeutics's Book Value per Share for the quarter that ended in Mar. 2024 is
Book Value per Share | = | (Total Stockholders Equity | - | Preferred Stock) | / | Shares Outstanding (EOP) |
= | (-72.363 | - | 0) | / | 33.632 | |
= | -2.15 |
2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.
BioXcel Therapeutics's Debt-to-Equity for the quarter that ended in Mar. 2024 is
Debt-to-Equity | = | Total Debt | / | Total Stockholders Equity | ||
= | (Short-Term Debt & Capital Lease Obligation | + | Long-Term Debt & Capital Lease Obligation) | / | Total Stockholders Equity | |
= | (0 | + | 101.983) | / | -72.363 | |
= | -1.41 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of BioXcel Therapeutics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Vimal Mehta | director, officer: CEO, President, Secretary | 780 EAST MAIN STREET, C/O BIOXCEL THERAPEUTICS, INC., BRANFORD CT 06405 |
Richard I Steinhart | officer: Chief Financial Officer | 125 ELM STREET, NEW CANAAN CT 06840 |
Javier Rodriguez | officer: SEE REMARKS | C/O BIOXCEL THERAPEUTICS, INC., 555 LONG WHARF DRIVE, NEW HAVEN CT 06511 |
Krishnan Nandabalan | director, 10 percent owner | 228 VILLAGE POND ROAD, GUILFORD CT 06437 |
Akrati Agarwal | 10 percent owner | 2614 BOSTON POST ROAD, SUITE #33B, GUILFORD CT 06437 |
Michael James Aiello | 10 percent owner | 10 TEMPLETON ROAD, WALLINGFORD CT 06492 |
Krunal Dilip Patel | 10 percent owner | 2614 BOSTON POST ROAD, SUITE #33B, GUILFORD CT 06437 |
Alka Sood | 10 percent owner | 2614 BOSTON POST ROAD, SUITE #33B, GUILFORD CT 06437 |
Pardeep Kumar Sood | 10 percent owner | 2614 BOSTON POST ROAD, SUITE #33B, GUILFORD CT 06437 |
Vipin Agarwal | 10 percent owner | 2614 BOSTON POST ROAD, SUITE #33B, GUILFORD CT 06437 |
Rashmi Agarwal | 10 percent owner | 2614 BOSTON POST ROAD, SUITE #33B, GUILFORD CT 06437 |
Jatin Markand Patel | 10 percent owner | 2614 BOSTON POST ROAD, SUITE #33B, GUILFORD CT 06437 |
Bina Jatin Patel | 10 percent owner | 2614 BOSTON POST ROAD, SUITE #33B, GUILFORD CT 06437 |
Diwakar Jain | 10 percent owner | 2614 BOSTON POST ROAD, SUITE #33B, GUILFORD CT 06437 |
Anita Jain | 10 percent owner | 2614 BOSTON POST ROAD, SUITE #33B, GUILFORD CT 06437 |
From GuruFocus
By Business Wire • 09-02-2023
By Business Wire • 09-01-2023
By PRNewswire • 08-28-2023
By PRNewswire • 09-02-2023
By Marketwired • 09-01-2023
By Marketwired • 08-29-2023
By Marketwired • 10-04-2023
By Marketwired • 10-10-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.